Author/Authors :
Hotta, Akihiro Department of Diagnostic Radiology - National Hospital Organization - Kure Medical Center and Chugoku Cancer Center, Hiroshima, Japan , Ishikawa, Masaki Department of Diagnostic Radiology - National Hospital Organization - Kure Medical Center and Chugoku Cancer Center, Hiroshima, Japan , Tachikake, Toshihiro Department of Diagnostic Radiology - Hiroshima City Hiroshima Citizens Hospital, Hiroshima, Japan , Matsuura, Noriaki Department of Diagnostic Radiology - National Hospital Organization - Kure Medical Center and Chugoku Cancer Center, Hiroshima, Japan , Toyota, Naoyuki Department of Diagnostic Radiology - National Hospital Organization - Kure Medical Center and Chugoku Cancer Center, Hiroshima, Japan , Awai, Kazuo Department of Diagnostic Radiology - Graduate School of Biomedical and Health Sciences - Hiroshima University, Hiroshima, Japan
Abstract :
Background
Cone-beam computed tomography (CBCT) has been widely used during transcatheter arterial chemoembolization for hepatocellular carcinoma.
Purpose
To evaluate the sensitivity of CBCT for the detection of hepatocellular carcinomas and the tumor feeders by comparing celiac artery (CA) and common hepatic artery (CHA) injection.
Material and methods
We retrospectively enrolled 30 patients (52 hepatocellular carcinoma lesions) who had undergone CBCT-assisted transcatheter arterial chemoembolization. In 17 procedures (28 hepatocellular carcinomas) we acquired CBCT scans using CA injections (CBCT-CA) and in 18 (24 hepatocellular carcinomas) we used CHA injections (CBCT-CHA). Of the 30 patients, 5 underwent CBCT-CA and CBCT-CHA at different transcatheter arterial chemoembolization procedures. We performed inter-group comparisons of the detectability of hepatocellular carcinoma, the feeding artery, the intrahepatic artery branch order, and the tumor-to-liver contrast.
Results
CBCT-CA detected all 28 hepatocellular carcinomas and 27 of their feeders (96.4%); CBCT-CHA identified 22 of 24 hepatocellular carcinomas (91.7%) and 21 of their feeders (95.5%). There was no significant inter-group difference in the detectability of hepatocellular carcinoma lesions (p = 0.21) or feeding arteries (p = 0.69). CBCT-CHA was superior for the assessment of the tumor-to-liver contrast and the intrahepatic artery branch order (both: p < 0.01).
Conclusion
CBCT-CA and CBCT-CHA were equally useful for the detection of hepatocellular carcinoma and of the feeding artery, although CBCT-CHA yields better visualization of hepatocellular carcinoma and the hepatic artery. Thus CA injection seems sufficient for lesion and vessel detection when the insertion of an angiographic catheter into the CHA is difficult.